Prevention of breast cancer-related lymphoedema following axillary lymph node clearance

Not Applicable

Recruiting

• Conditions: Breast cancer; Lymphoedema; Cancer - Breast

• Registration Number: ACTRN12612000639820
• Lead Sponsor: orfolk & Norwich University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-06-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 178

Inclusion Criteria

Patients undergoing axillary lymph node clearance for primary operable breast cancer

Exclusion Criteria

Recurrent breast cancer
Previous axillary surgery
Previous axillary radiotherapy
Previous axillary/arm pathology leading to arm volume changes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
imb volume, calculated assuming the arm is a cylinder of varying radius on the basis of arm circumference measurements starting at 20cm proximal to the cuticle of the middle finger and at 4cm intervals proximal to that.[3-4 months after the end of the intervention, then 6, 12, 18, 24 & 36 months]

Secondary Outcome Measures

Name	Time	Method
Validation of the use of bio-impedance technology (QuadScan 4000) to calculate the presence of lymphoedema against standard validated limb volume measurements.[3-4 months after the end of the intervention, then 6, 12, 18, 24 & 36 months]